|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Depreciation and amortization | |||||
| Impairment of investments | |||||
| Impairment of investment | |||||
| Impairment of intangible assets | |||||
| Impairment of goodwill | |||||
| impairment of ROU | |||||
| Accretion of debt discount and issuance cost | |||||
| Share-based compensation | |||||
| Shares issued for in process research and development | |||||
| Bad debt expense | |||||
| Change in fair value of derivative liabilities | |||||
| Gain on marketable securities | |||||
| Gain on Forgiveness of debt | |||||
| Loss on settlement of vendor liabilities | |||||
| (Gain) loss on extinguishment of debt | |||||
| Settlement of vendor liabilities | |||||
| Change in fair value of derivative liability | |||||
| Derivative Expense | |||||
| Loss on marketable securities | |||||
| Non cash lease expense | |||||
| Reserve for obsolete inventory | |||||
| Equity interest granted for other income | |||||
| Equity in net loss from unconsolidated investment | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses | |||||
| Inventory | |||||
| Accounts receivable | |||||
| Deposits and other assets | |||||
| Deferred revenue | |||||
| Accounts payable and accrued expenses | |||||
| Unrecognized tax benefit | |||||
| Operating lease liability | |||||
| Net Cash Used In Operating Activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES: | |||||
| Cash paid for property and equipment | |||||
| Cash paid for marketable securities | |||||
| Deposits | |||||
| Cash paid for minority investment in business | |||||
| Cash paid for equity method investment | |||||
| Cash paid for investments in marketable securities | |||||
| Sale of marketable securities | |||||
| Cash received from the Sale of non-controlling interest in OG Collection Inc. | |||||
| Cash consideration for acquisition | |||||
| Purchases of digital assets | |||||
| Sale of digital assets | |||||
| Net Cash Provided By (Used In) Investing Activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES: | |||||
| Proceeds from the exercise of warrant | |||||
| Net proceeds from issuance of notes | |||||
| Proceeds from issuance of demand loan | |||||
| Repayment of demand Loan | |||||
| Repayment of notes | |||||
| Proceeds from issuance of convertible note | |||||
| Repayment of convertible notes | |||||
| Proceeds from issuance of convertible notes - related party | |||||
| Proceeds from issuance of note payable - related party | |||||
| Repayment of note payable - related party | |||||
| Net cash received for preferred series E and warrants | |||||
| Proceeds from issuance of common stock and warrants | |||||
| Purchase of treasury stock and warrants | |||||
| Cash received for preferred series E and warrants | |||||
| Purchase of treasury stock | |||||
| Net Cash Provided By Financing Activities | |||||
| Effect of exchange rate changes on cash | |||||
| Effect of exchange rate changes on cash | |||||
| Net Change in Cash | |||||
| Cash - Beginning of period | |||||
| Cash - End of period | |||||
| SUPPLEMENTARY CASH FLOW INFORMATION: | |||||
| Interest | |||||
| Settlement of vendor liabilities | |||||
| Conversion of marketable debt securities into equity securities | |||||
| SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: | |||||
| Settlement of vendor liabilities | |||||
| Beneficial conversion feature on convertible notes | |||||
| Warrants issued with debt | |||||
| Shares issued with debt | |||||
| Cancellation of Treasury stock | |||||
| Conversion of note payable and interest into convertible notes | |||||
| Conversion of Demand loan into notes payable | |||||
| Issuance of common stock for prepaid services | |||||
| Recognition of Right-of-use asset and corresponding operating lease liability | |||||
| Deferred offering costs | |||||
| Common stock and warrants issued upon conversion of notes payable | |||||
| Shares issued for acquisition | |||||
| Reduction of ROU asset related to re-measurement of lease liability | |||||
| Repayment of promissory notes from Australian R&D credits | |||||
Loading...